Braidwell LP Has $27.89 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Braidwell LP decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 70,137 shares of the medical equipment provider’s stock after selling 7,160 shares during the period. Braidwell LP’s holdings in Intuitive Surgical were worth $27,892,000 as of its most recent filing with the SEC.

A number of other large investors also recently made changes to their positions in ISRG. Prosperity Consulting Group LLC raised its stake in Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after purchasing an additional 19 shares in the last quarter. Valeo Financial Advisors LLC lifted its stake in Intuitive Surgical by 0.4% during the fourth quarter. Valeo Financial Advisors LLC now owns 4,941 shares of the medical equipment provider’s stock worth $2,798,000 after purchasing an additional 21 shares during the last quarter. Dana Investment Advisors Inc. lifted its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Dana Investment Advisors Inc. now owns 1,140 shares of the medical equipment provider’s stock worth $646,000 after buying an additional 21 shares during the last quarter. Forefront Wealth Partners LLC lifted its holdings in shares of Intuitive Surgical by 2.6% in the fourth quarter. Forefront Wealth Partners LLC now owns 819 shares of the medical equipment provider’s stock worth $464,000 after acquiring an additional 21 shares during the last quarter. Finally, High Note Wealth LLC lifted its stake in Intuitive Surgical by 50.0% in the 4th quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 23 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent research reports. Wells Fargo & Company reiterated an “overweight” rating and set a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Raymond James Financial reissued an “outperform” rating and issued a $483.00 price objective (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. The Goldman Sachs Group set a $558.00 price objective on Intuitive Surgical in a report on Wednesday, May 27th. Citigroup lowered their target price on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Finally, Mizuho set a $500.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research report on Wednesday, July 15th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $508.68.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $371.88 on Thursday. The company has a market capitalization of $131.38 billion, a P/E ratio of 42.60, a price-to-earnings-growth ratio of 2.79 and a beta of 1.47. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The company’s 50 day moving average price is $382.80 and its 200-day moving average price is $429.86.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. During the same period in the prior year, the company posted $1.81 earnings per share. Intuitive Surgical’s revenue for the quarter was up 18.4% compared to the same quarter last year. Analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insider Activity

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the executive vice president owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the sale, the director owned 1,245,679 shares of the company’s stock, valued at approximately $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 11,658 shares of company stock worth $4,649,835. 0.60% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.